What is SLEEP NUMBER CORP's earnings per share (EPS)?

SLEEP NUMBER CORP (SNBRQ) reported diluted earnings per share of -$5.77 for fiscal year 2025. This represents a -541.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

SLEEP NUMBER CORP (SNBRQ) Financials

SNBRQ

Trailing 12 months to April 4, 2026

Revenue $1.3B -16.7% YoY

Net Income -$173.7M -707.8% YoY

EPS (Diluted) -$7.57 -696.8% YoY

Free Cash Flow -$23.7M +15.6% YoY

Market Cap $371K as of Sep 11, 2026

Price / Sales 0.0x on $1.3B revenue, trailing 12 months to April 4, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to April 4, 2026

Price / Book n/m negative shareholder equity, so no book multiple, Q1 FY2027

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 11, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Apr 4, 2026 Reported May 12, 2026 Currency USD FYE January

Newest figures come from the 10-Q for Q1 FY2027, filed May 12, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SNBRQ SEC filings page.

SLEEP NUMBER CORP (SNBRQ) reported $1.3B in revenue over the twelve months to Apr 4, 2026, down 16.7% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial health score not available

SLEEP NUMBER CORP does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

-0.75

SLEEP NUMBER CORP scores -0.75, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($371K) relative to total liabilities ($1.3B). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

2/8

SLEEP NUMBER CORP passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing

N/A

SLEEP NUMBER CORP reported a net loss of $132.0M while operations used $3.3M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

SLEEP NUMBER CORP reported an operating loss of $46.6M against $49.4M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$319.0M

YoY-18.9%

QoQ-8.2%

5Y CAGR-10.9%

10Y CAGR-1.0%

SLEEP NUMBER CORP generated $319.0M in revenue in Q1 2027. This represents a decrease of 18.9% from the same quarter a year earlier. Against the prior quarter it is down 8.2%.

EBITDA

-$24.5M

YoY-246.7%

QoQ-597.2%

SLEEP NUMBER CORP's EBITDA was -$24.5M in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 246.7% from the same quarter a year earlier. Against the prior quarter it is down 597.2%.

Net Income

-$50.3M

YoY-481.7%

QoQ+14.1%

SLEEP NUMBER CORP reported -$50.3M in net income in Q1 2027. This represents a decrease of 481.7% from the same quarter a year earlier. Against the prior quarter it is up 14.1%.

EPS (Diluted)

-$2.19

YoY-476.3%

QoQ+14.5%

SLEEP NUMBER CORP earned -$2.19 per diluted share (EPS) in Q1 2027. This represents a decrease of 476.3% from the same quarter a year earlier. Against the prior quarter it is up 14.5%.

Cash & Balance Sheet

Free Cash Flow

-$13.2M

YoY-82.6%

QoQ-1951.6%

SLEEP NUMBER CORP recorded an outflow of $13.2M in free cash flow in Q1 2027, representing a cash shortfall after capex. This represents a decrease of 82.6% from the same quarter a year earlier. Against the prior quarter it is down 1951.6%.

Cash & Debt

$1.5M

YoY-12.2%

QoQ-12.3%

5Y CAGR-7.9%

10Y CAGR-25.8%

SLEEP NUMBER CORP held $1.5M in cash as of Q1 2027; long-term debt is not reported for that period.

Shares Outstanding

23M

YoY+1.7%

QoQ+0.8%

5Y CAGR-1.2%

10Y CAGR-6.8%

SLEEP NUMBER CORP had 23M shares outstanding in Q1 2027. This represents an increase of 1.7% from the same quarter a year earlier. Against the prior quarter it is up 0.8%.

Dividends Per Share

Not reported for Q1 2027.

Margins & Returns

Gross Margin

57.9%

YoY-3.3pp

QoQ+2.2pp

5Y change-4.7pp

10Y change-1.4pp

SLEEP NUMBER CORP's gross margin was 57.9% in Q1 2027, indicating the percentage of revenue retained after direct costs. This is down 3.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.2 percentage points.

Operating Margin

-11.6%

YoY-12.0pp

QoQ-9.2pp

5Y change-25.0pp

10Y change-17.2pp

SLEEP NUMBER CORP's operating margin was -11.6% in Q1 2027, reflecting core business profitability. This is down 12.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 9.2 percentage points.

Net Margin

-15.8%

YoY-13.6pp

QoQ+1.1pp

5Y change-27.5pp

10Y change-19.4pp

SLEEP NUMBER CORP's net profit margin was -15.8% in Q1 2027, showing the share of revenue converted to profit. This is down 13.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.1 percentage points.

Return on Equity

Not reported for Q1 2027.

Capital Allocation

R&D Spending

$5.3M

YoY-50.9%

QoQ-15.0%

5Y CAGR-16.6%

SLEEP NUMBER CORP invested $5.3M in research and development in Q1 2027. This represents a decrease of 50.9% from the same quarter a year earlier. Against the prior quarter it is down 15.0%.

Share Buybacks

$373K

YoY-33.7%

QoQ+92.3%

5Y CAGR-70.9%

10Y CAGR-38.9%

SLEEP NUMBER CORP spent $373K on share buybacks in Q1 2027, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 33.7% from the same quarter a year earlier. Against the prior quarter it is up 92.3%.

Capital Expenditures

$5.4M

YoY+18.3%

QoQ+116.0%

5Y CAGR-14.0%

10Y CAGR-7.8%

SLEEP NUMBER CORP invested $5.4M in capex in Q1 2027, funding long-term assets and infrastructure. This represents an increase of 18.3% from the same quarter a year earlier. Against the prior quarter it is up 116.0%.

SNBRQ Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SNBRQ quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$1.3B	$1.4B-16.1%	$1.7B-10.9%	$1.9B-10.7%	$2.1B-3.2%	$2.2B+17.7%	$1.9B+9.3%	$1.7B+10.9%	$1.5B+6.0%	$1.4B+10.2%	$1.3B+8.0%	$1.2B+4.9%	$1.2B+20.5%	$960.2M+2.7%	$935.0M+25.8%	$743.2M
Cost of Revenue	$560.1M	$578.5M-14.9%	$679.5M-14.9%	$799.0M-12.4%	$912.0M+5.3%	$866.1M+23.6%	$700.6M+8.4%	$646.4M+7.1%	$603.6M+10.3%	$547.1M+9.2%	$501.1M+6.0%	$472.9M+5.1%	$449.9M+25.5%	$358.4M+5.9%	$338.4M+24.0%	$272.9M
Gross Profit	$777.0M	$833.0M-16.9%	$1.0B-7.9%	$1.1B-9.5%	$1.2B-8.8%	$1.3B+14.1%	$1.2B+9.9%	$1.1B+13.4%	$928.0M+3.4%	$897.3M+10.8%	$810.2M+9.4%	$740.8M+4.8%	$706.9M+17.5%	$601.8M+0.9%	$596.5M+26.8%	$470.3M
R&D Expenses	$28.4M	$33.9M-25.0%	$45.3M-18.9%	$55.8M-9.3%	$61.5M+5.1%	$58.5M+43.1%	$40.9M+17.1%	$35.0M+21.5%	$28.8M+3.5%	$27.8M-0.7%	$28.0M+75.3%	$16.0M+94.0%	$8.2M-13.1%	$9.5M+53.0%	$6.2M+48.4%	$4.2M
SG&A Expenses	$125.6M	$130.7M-12.9%	$150.0M+2.3%	$146.6M-4.3%	$153.3M-5.0%	$161.4M+1.5%	$159.0M+15.3%	$138.0M+15.6%	$119.4M-6.2%	$127.3M+16.0%	$109.7M+10.5%	$99.2M+16.9%	$84.9M+35.9%	$62.4M-6.5%	$66.8M+14.9%	$58.1M
Operating Income	-$85.3M	-$46.6M-303.7%	$22.9M-0.3%	$22.9M-66.2%	$67.9M-64.9%	$193.5M+4.7%	$184.9M+64.9%	$112.1M+21.3%	$92.4M+0.6%	$91.9M+19.9%	$76.7M+2.1%	$75.1M-26.2%	$101.7M+12.2%	$90.7M-24.3%	$119.8M+32.4%	$90.5M
EBITDA	N/A	$9.0M-89.9%	$89.2M-8.0%	$97.0M-28.3%	$135.3M-46.7%	$253.9M+3.0%	$246.5M+41.7%	$174.0M+12.7%	$154.4M+0.8%	$153.2M+14.5%	$133.8M+9.0%	$122.7M-13.3%	$141.6M+16.5%	$121.5M-13.3%	$140.2M+34.8%	$104.0M
Interest Expense	$51.4M	$49.4M+2.1%	$48.4M+13.3%	$42.7M+124.9%	$19.0M+404.0%	-$6.2M+30.0%	-$8.9M-177.0%	$11.6M+96.1%	$5.9M+506.3%	$975K+20.2%	$811K+406.9%	$160K+201.9%	$53K+1.9%	$52K-43.5%	$92K-51.1%	$188K
Income Tax	$36.9M	$36.0M+797.1%	-$5.2M-15.6%	-$4.5M-136.4%	$12.3M-63.4%	$33.5M-8.8%	$36.8M+97.1%	$18.7M+9.9%	$17.0M-34.6%	$26.0M+5.9%	$24.5M-1.6%	$24.9M-27.0%	$34.1M+10.4%	$30.9M-26.2%	$41.9M+40.0%	$29.9M
Net Income	-$173.7M	-$132.0M-549.2%	-$20.3M-32.9%	-$15.3M-141.8%	$36.6M-76.2%	$153.7M+10.4%	$139.2M+70.1%	$81.8M+17.7%	$69.5M+6.9%	$65.1M+26.6%	$51.4M+1.8%	$50.5M-25.7%	$68.0M+13.1%	$60.1M-23.1%	$78.1M+29.1%	$60.5M
EPS (Basic)	N/A	-$5.77-541.1%	-$0.90-32.4%	-$0.68-141.7%	$1.63-74.5%	$6.40+27.2%	$5.03+80.9%	$2.78+41.1%	$1.97+24.7%	$1.58+42.3%	$1.11+12.1%	$0.99-22.0%	$1.27+15.5%	$1.10-22.0%	$1.41+28.2%	$1.10
EPS (Diluted)	-$7.57	-$5.77-541.1%	-$0.90-32.4%	-$0.68-142.5%	$1.60-74.0%	$6.16+25.7%	$4.90+81.5%	$2.70+40.6%	$1.92+23.9%	$1.55+40.9%	$1.10+13.4%	$0.97-22.4%	$1.25+15.7%	$1.08-21.2%	$1.37+28.0%	$1.07
Diluted Shares (Avg)	N/A	23M+1.2%	23M+0.8%	22M-1.9%	23M-8.4%	25M-12.2%	28M-6.3%	30M-16.1%	36M-14.1%	42M-10.3%	47M-10.0%	52M-3.9%	54M-2.9%	56M-2.2%	57M+1.1%	56M

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Revenue	$319.0M-18.9%	$347.4M-7.8%	$342.9M-19.6%	$327.9M-19.7%	$393.3M-16.4%	$376.8M-12.3%	$426.6M-9.7%	$408.4M-11.0%
Cost of Revenue	$134.4M-12.0%	$154.1M+1.9%	$137.5M-17.7%	$134.2M-19.6%	$152.7M-21.4%	$151.2M-19.0%	$167.1M-17.1%	$166.9M-14.2%
Gross Profit	$184.6M-23.2%	$193.3M-14.3%	$205.4M-20.9%	$193.7M-19.8%	$240.5M-12.9%	$225.6M-7.1%	$259.5M-4.3%	$241.5M-8.6%
R&D Expenses	$5.3M-50.9%	$6.3M-40.9%	$7.3M-30.8%	$9.4M-18.6%	$10.9M-12.4%	$10.7M-19.8%	$10.6M-16.2%	$11.6M-25.0%
SG&A Expenses	$33.6M-13.0%	$30.7M-19.8%	$31.8M-3.9%	$29.6M-25.2%	$38.6M-1.2%	$38.2M+7.8%	$33.1M+3.5%	$39.6M-0.6%
Operating Income	-$36.9M-2092.2%	-$8.1M-389.8%	-$40.3M-578.1%	-$75K-101.2%	$1.9M-66.6%	$2.8M+114.2%	$8.4M+56.5%	$6.1M-45.5%
EBITDA	-$24.5M-246.7%	$4.9M-73.7%	-$26.8M-208.7%	$14.2M-37.8%	$16.7M-27.5%	$18.8M+2576.9%	$24.6M+3.4%	$22.8M-23.3%
Interest Expense	$13.1M+18.2%	$13.9M+18.2%	$12.7M+5.2%	$11.7M-4.4%	$11.1M-9.9%	$11.7M-62.0%	$12.1M+10.0%	$12.3M+23.3%
Income Tax	$338K+157.8%	$36.6M+950.8%	-$13.2M-2601.8%	$13.2M+1301.4%	-$585K-180.7%	-$4.3M+39.5%	-$489K+85.0%	-$1.1M-309.7%
Net Income	-$50.3M-481.7%	-$58.6M-1155.1%	-$39.8M-1168.8%	-$25.0M-395.2%	-$8.6M-15.6%	-$4.7M+81.5%	-$3.1M-35.3%	-$5.1M-769.9%
EPS (Basic)	-$2.19-476.3%	-$2.56-1119.0%	-$1.73-1135.7%	-$1.09-395.5%	-$0.38-15.2%	-$0.21+81.3%	-$0.14-40.0%	-$0.22-833.3%
EPS (Diluted)	-$2.19-476.3%	-$2.56-1119.0%	-$1.73-1135.7%	-$1.09-395.5%	-$0.38-15.2%	-$0.21+81.3%	-$0.14-40.0%	-$0.22-833.3%
Diluted Shares (Avg)	23M+1.3%	N/A	23M+1.4%	23M+1.3%	23M+0.9%	N/A	23M+0.7%	23M+0.5%

SNBRQ Balance Sheet

SNBRQ quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$680.1M-21.0%	$860.8M-9.5%	$950.9M-0.3%	$953.9M+3.7%	$919.5M+14.9%	$800.1M-0.7%	$806.0M+71.4%	$470.1M-0.4%	$471.8M+3.2%	$457.2M-8.7%	$500.9M+5.6%	$474.2M+24.2%	$381.8M+11.6%	$342.0M+30.2%	$262.7M
Current Assets	$150.0M-17.3%	$181.3M-12.1%	$206.1M+4.2%	$197.8M-4.8%	$207.6M+14.2%	$181.8M+13.4%	$160.4M+6.3%	$150.9M-1.1%	$152.5M+10.2%	$138.3M-24.2%	$182.4M-21.6%	$232.6M+22.7%	$189.5M-10.0%	$210.6M+10.1%	$191.2M
Cash & Equivalents	$1.7M-13.2%	$1.9M-23.2%	$2.5M+41.7%	$1.8M-25.0%	$2.4M-43.7%	$4.2M+166.4%	$1.6M-1.2%	$1.6M-55.8%	$3.7M-68.6%	$11.6M-44.7%	$21.0M-59.6%	$52.0M-10.7%	$58.2M-33.8%	$87.9M-24.4%	$116.3M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0-100.0%	$6.6M-90.6%	$69.6M+33.5%	$52.2M+1.7%	$51.3M+156.1%	$20.0M
Inventory	$82.2M-20.3%	$103.2M-10.6%	$115.4M+1.2%	$114.0M+7.9%	$105.6M+29.8%	$81.4M-6.6%	$87.1M+2.6%	$84.9M+0.7%	$84.3M+12.4%	$75.0M-13.4%	$86.6M+61.8%	$53.5M+33.3%	$40.2M+12.9%	$35.6M+43.1%	$24.9M
Accounts Receivable	$15.5M-11.5%	$17.5M-34.8%	$26.9M+3.3%	$26.0M+1.1%	$25.7M-19.3%	$31.9M+59.5%	$20.0M-19.4%	$24.8M+28.4%	$19.3M-2.0%	$19.7M-32.1%	$29.0M+47.3%	$19.7M+31.5%	$15.0M-9.8%	$16.6M+20.0%	$13.8M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0-100.0%	$8.6M-80.8%	$44.4M+28.3%	$34.6M-10.4%	$38.6M+284.8%	$10.0M
Goodwill	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%	$64.0M-0.1%	$64.0M+614.6%	$9.0M0.0%	$9.0M+214.5%	$2.9M0.0%	$2.9M
Total Liabilities	$1.3B-4.1%	$1.3B-5.8%	$1.4B0.0%	$1.4B+3.5%	$1.3B+31.3%	$1.0B+6.1%	$965.5M+66.6%	$579.7M+51.5%	$382.7M+28.9%	$296.8M+6.6%	$278.6M+28.2%	$217.3M+38.8%	$156.5M+5.5%	$148.3M+11.3%	$133.3M
Current Liabilities	$912.5M+0.5%	$908.0M-3.0%	$936.1M+0.7%	$929.8M+2.5%	$906.8M+38.2%	$655.9M+10.3%	$594.8M+21.7%	$488.7M+59.5%	$306.4M+36.0%	$225.3M+0.2%	$224.9M+20.3%	$187.1M+36.4%	$137.2M+3.1%	$133.1M+11.8%	$119.0M
Non-Current Liabilities	$346.0M-14.4%	$404.4M-11.5%	$456.7M-1.2%	$462.3M+5.6%	$437.7M+18.9%	$368.2M-0.7%	$370.7M+307.3%	$91.0M+19.3%	$76.3M+6.7%	$71.5M+33.4%	$53.6M+77.3%	$30.2M+56.1%	$19.4M+26.9%	$15.3M-88.5%	$133.3M
Total Equity	-$578.5M-28.1%	-$451.6M-2.2%	-$441.9M-0.9%	-$438.2M-3.1%	-$425.0M-89.7%	-$224.0M-40.5%	-$159.4M-45.5%	-$109.5M-222.9%	$89.2M-44.4%	$160.3M-27.9%	$222.3M-13.5%	$256.9M+14.1%	$225.2M+16.3%	$193.7M+49.7%	$129.4M
Retained Earnings	-$611.2M-27.5%	-$479.2M-4.4%	-$458.9M-3.4%	-$443.6M-3.4%	-$429.2M-91.4%	-$224.2M-40.4%	-$159.7M-45.4%	-$109.9M-223.8%	$88.8M-44.5%	$159.9M-27.9%	$221.9M-13.5%	$256.4M+16.9%	$219.3M+37.7%	$159.2M+96.3%	$81.1M

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Total Assets	$641.0M-23.4%	$680.1M-21.0%	$749.4M-13.3%	$804.5M-9.0%	$836.8M-7.9%	$860.8M-9.5%	$864.7M-10.0%	$883.6M-8.4%
Current Assets	$143.5M-18.2%	$150.0M-17.3%	$169.8M-0.3%	$175.5M-1.0%	$175.4M-3.1%	$181.3M-12.1%	$170.3M-14.0%	$177.4M-14.9%
Cash & Equivalents	$1.5M-12.2%	$1.7M-13.2%	$1.3M-20.6%	$1.3M-33.2%	$1.7M-18.2%	$1.9M-23.2%	$1.6M+75.7%	$2.0M+12.3%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$78.2M-24.7%	$82.2M-20.3%	$89.8M-3.4%	$99.5M+3.8%	$103.9M+2.9%	$103.2M-10.6%	$93.0M-19.9%	$95.8M-21.1%
Accounts Receivable	$13.4M-6.1%	$15.5M-11.5%	$13.9M-18.3%	$16.0M-21.0%	$14.2M-34.8%	$17.5M-34.8%	$17.0M-8.6%	$20.3M-15.9%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%	$64.0M0.0%
Total Liabilities	$1.3B-2.0%	$1.3B-4.1%	$1.3B-3.3%	$1.3B-3.4%	$1.3B-4.5%	$1.3B-5.8%	$1.3B-4.9%	$1.3B-3.9%
Current Liabilities	$931.7M+3.0%	$912.5M+0.5%	$898.8M+0.5%	$903.2M+0.3%	$904.4M-0.2%	$908.0M-3.0%	$894.0M-2.8%	$900.6M-2.3%
Non-Current Liabilities	$335.6M-13.8%	$346.0M-14.4%	$371.9M-11.3%	$382.0M-11.2%	$389.3M-13.1%	$404.4M-11.5%	$419.4M-9.3%	$430.0M-7.0%
Total Equity	-$626.3M-37.1%	-$578.5M-28.1%	-$521.3M-16.2%	-$480.7M-7.5%	-$456.8M-2.5%	-$451.6M-2.2%	-$448.8M-6.7%	-$447.0M-6.6%
Retained Earnings	-$661.5M-35.6%	-$611.2M-27.5%	-$552.6M-16.5%	-$512.9M-8.8%	-$487.8M-4.6%	-$479.2M-4.4%	-$474.5M-9.4%	-$471.4M-9.3%

Not reported in any period shown, so not listed: Long-Term Debt.

SNBRQ Cash Flow Statement

SNBRQ quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$8.4M	-$3.3M-112.1%	$27.1M+400.7%	-$9.0M-125.0%	$36.1M-88.0%	$300.0M+7.3%	$279.7M+47.8%	$189.2M+43.8%	$131.5M-23.8%	$172.6M+13.8%	$151.6M+40.5%	$107.9M-25.3%	$144.5M+64.0%	$88.1M-12.4%	$100.6M+10.5%	$91.0M
Depreciation & Amortization	N/A	$55.6M-16.2%	$66.4M-10.4%	$74.0M+9.9%	$67.4M+11.6%	$60.4M-1.9%	$61.6M-0.5%	$61.9M-0.2%	$62.0M+1.1%	$61.3M+7.2%	$57.2M+20.0%	$47.6M+19.6%	$39.8M+29.2%	$30.8M+51.0%	$20.4M+50.6%	$13.5M
Stock-Based Compensation	N/A	$6.3M-45.1%	$11.4M-23.0%	$14.9M+12.3%	$13.2M-43.0%	$23.2M+6.4%	$21.8M+31.0%	$16.7M+46.0%	$11.4M-27.6%	$15.8M+31.8%	$12.0M+16.2%	$10.3M+51.4%	$6.8M+60.6%	$4.2M-58.9%	$10.3M+107.3%	$5.0M
Capital Expenditures	$15.2M	$14.4M-38.7%	$23.5M-58.8%	$57.1M-17.9%	$69.5M+3.8%	$66.9M+80.3%	$37.1M-37.4%	$59.2M+30.2%	$45.5M-23.9%	$59.8M+3.4%	$57.9M-32.4%	$85.6M+11.7%	$76.6M-0.3%	$76.8M+48.9%	$51.6M+119.3%	$23.5M
Free Cash Flow	-$23.7M	-$17.7M-586.3%	$3.6M+105.5%	-$66.1M-98.4%	-$33.3M-114.3%	$233.1M-3.9%	$242.6M+86.7%	$129.9M+51.0%	$86.0M-23.7%	$112.8M+20.2%	$93.8M+319.5%	$22.4M-67.1%	$67.9M+501.0%	$11.3M-77.0%	$49.0M-27.4%	$67.5M
Investing Cash Flow	-$18.5M	-$17.7M+32.7%	-$26.3M+54.9%	-$58.4M+17.4%	-$70.6M-5.9%	-$66.6M-70.8%	-$39.0M+31.1%	-$56.6M-25.2%	-$45.2M+24.3%	-$59.8M-40.1%	-$42.7M	N/A	N/A	-$87.3M+22.1%	-$112.1M-99.5%	-$56.2M
Financing Cash Flow	$26.7M	$20.7M+1537.4%	-$1.4M-102.1%	$68.1M+101.1%	$33.9M+114.4%	-$235.2M+1.2%	-$238.0M-79.5%	-$132.6M-50.1%	-$88.3M+28.7%	-$123.9M-4.7%	-$118.4M	N/A	N/A	-$30.5M-80.8%	-$16.9M-413.5%	$5.4M
Share Buybacks	$1.0M	$1.2M+57.9%	$768K-79.5%	$3.7M-94.2%	$64.2M-83.2%	$382.4M+62.3%	$235.6M+42.7%	$165.1M-39.4%	$272.4M+75.5%	$155.2M+22.5%	$126.7M+26.4%	$100.2M+115.5%	$46.5M+10.5%	$42.1M+20.6%	$34.9M+9304.9%	$371K

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Operating Cash Flow	-$7.8M-195.2%	$1.9M+107.9%	-$6.4M-123.3%	$3.8M+137.4%	-$2.6M-107.8%	-$23.7M+42.0%	$27.3M+108.5%	-$10.2M-7457.6%
Depreciation & Amortization	$12.4M-16.6%	$13.0M-18.8%	$13.5M-16.5%	$14.3M-14.6%	$14.8M-15.2%	$16.0M-15.3%	$16.2M-12.2%	$16.7M-9.9%
Stock-Based Compensation	$2.8M-28.5%	N/A	-$788K-155.0%	$1.5M-61.2%	$4.0M-4.0%	N/A	$1.4M+45.8%	$4.0M-24.0%
Capital Expenditures	$5.4M+18.3%	$2.5M-59.9%	$3.8M+22.0%	$3.5M-27.6%	$4.6M-50.6%	$6.3M-30.4%	$3.1M-82.7%	$4.8M-66.8%
Free Cash Flow	-$13.2M-82.6%	-$643K+97.9%	-$10.2M-142.2%	$369K+102.5%	-$7.2M-129.6%	-$30.0M+39.9%	$24.2M+580.7%	-$15.0M-5.6%
Investing Cash Flow	-$5.4M-18.3%	-$2.5M+59.9%	-$3.8M-28.4%	-$6.7M-41.2%	-$4.6M+62.5%	-$6.3M+30.3%	-$3.0M+84.3%	-$4.8M+67.7%
Financing Cash Flow	$13.0M+86.4%	$1.1M-96.5%	$10.1M+140.8%	$2.6M-82.8%	$7.0M+131.7%	$30.3M-41.1%	-$24.7M-594.2%	$14.9M-0.2%
Share Buybacks	$373K-33.7%	$194K+385.0%	$75K-35.3%	$381K+807.1%	$563K-1.2%	$40K+11.1%	$116K-44.8%	$42K-69.6%

Not reported in any period shown, so not listed: Dividends Paid.

SNBRQ Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SNBRQ quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	59.0%-0.6pp	59.6%+1.9pp	57.7%+0.8pp	56.9%-3.5pp	60.4%-1.9pp	62.3%+0.3pp	61.9%+1.3pp	60.6%-1.5pp	62.1%+0.3pp	61.8%+0.8pp	61.0%-0.1pp	61.1%-1.6pp	62.7%-1.1pp	63.8%+0.5pp	63.3%
Operating Margin	-3.3%-4.7pp	1.4%+0.1pp	1.2%-2.0pp	3.2%-5.7pp	8.9%-1.1pp	10.0%+3.4pp	6.6%+0.6pp	6.0%-0.3pp	6.4%+0.5pp	5.9%-0.3pp	6.2%-2.6pp	8.8%-0.6pp	9.4%-3.4pp	12.8%+0.6pp	12.2%
Net Margin	-9.3%-8.1pp	-1.2%-0.4pp	-0.8%-2.5pp	1.7%-5.3pp	7.0%-0.5pp	7.5%+2.7pp	4.8%+0.3pp	4.5%0.0pp	4.5%+0.6pp	3.9%-0.2pp	4.2%-1.7pp	5.9%-0.4pp	6.3%-2.1pp	8.3%+0.2pp	8.1%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	73.0%+40.9pp	32.1%+9.3pp	22.7%-3.7pp	26.5%-0.2pp	26.7%-13.6pp	40.3%-6.4pp	46.7%
Return on Assets	-19.4%-17.0pp	-2.4%-0.8pp	-1.6%-5.4pp	3.8%-12.9pp	16.7%-0.7pp	17.4%+7.2pp	10.2%-4.6pp	14.8%+1.0pp	13.8%+2.5pp	11.3%+1.2pp	10.1%-4.2pp	14.3%-1.4pp	15.7%-7.1pp	22.8%-0.2pp	23.0%
Current Ratio	0.160.0x	0.200.0x	0.220.0x	0.210.0x	0.230.0x	0.280.0x	0.270.0x	0.31-0.2x	0.50-0.1x	0.61-0.2x	0.81-0.4x	1.24-0.1x	1.38-0.2x	1.580.0x	1.61
Debt-to-Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	4.29+2.4x	1.85+0.6x	1.25+0.4x	0.85+0.2x	0.70-0.1x	0.77-0.3x	1.03
Asset Turnover	2.08+0.1x	1.950.0x	1.99-0.2x	2.22-0.2x	2.38+0.1x	2.32+0.2x	2.11-1.2x	3.26+0.2x	3.06+0.2x	2.87+0.4x	2.420.0x	2.44-0.1x	2.52-0.2x	2.73-0.1x	2.83
FCF Margin	-1.3%-1.5pp	0.2%+3.7pp	-3.5%-1.9pp	-1.6%-12.3pp	10.7%-2.4pp	13.1%+5.4pp	7.6%+2.0pp	5.6%-2.2pp	7.8%+0.7pp	7.1%+5.3pp	1.8%-4.0pp	5.9%+4.7pp	1.2%-4.1pp	5.2%-3.8pp	9.1%

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Gross Margin	57.9%-3.3pp	55.6%-4.2pp	59.9%-0.9pp	59.1%-0.1pp	61.2%+2.5pp	59.9%+3.3pp	60.8%+3.5pp	59.1%+1.5pp
Operating Margin	-11.6%-12.0pp	-2.3%-3.1pp	-11.8%-13.7pp	0.0%-1.5pp	0.5%-0.7pp	0.7%+5.3pp	2.0%+0.8pp	1.5%-1.0pp
Net Margin	-15.8%-13.6pp	-16.9%-15.6pp	-11.6%-10.9pp	-7.6%-6.4pp	-2.2%-0.6pp	-1.2%+4.6pp	-0.7%-0.3pp	-1.2%-1.4pp
Return on Assets	-7.8%-6.8pp	-8.6%-8.1pp	-5.3%-5.0pp	-3.1%-2.5pp	-1.0%-0.2pp	-0.5%+2.1pp	-0.4%-0.1pp	-0.6%-0.7pp
Current Ratio	0.150.0x	0.160.0x	0.190.0x	0.190.0x	0.190.0x	0.200.0x	0.190.0x	0.200.0x
Asset Turnover	0.500.0x	0.51+0.1x	0.460.0x	0.41-0.1x	0.470.0x	0.440.0x	0.490.0x	0.460.0x
FCF Margin	-4.1%-2.3pp	-0.2%+7.8pp	-3.0%-8.6pp	0.1%+3.8pp	-1.8%-7.0pp	-8.0%+3.7pp	5.7%+6.7pp	-3.7%-0.6pp

Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity.

Note: Shareholder equity is negative (-$578.5M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.16), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Where SLEEP NUMBER CORP Ranks

Frequently Asked Questions

What is SLEEP NUMBER CORP's annual revenue?

SLEEP NUMBER CORP (SNBRQ) reported $1.4B in total revenue for fiscal year 2025. This represents a -16.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is SLEEP NUMBER CORP's revenue growing?

SLEEP NUMBER CORP (SNBRQ) revenue declined by 16.1% year-over-year, from $1.7B to $1.4B in fiscal year 2025.

Is SLEEP NUMBER CORP profitable?

No, SLEEP NUMBER CORP (SNBRQ) reported a net income of -$132.0M in fiscal year 2025, with a net profit margin of -9.3%.

What is SLEEP NUMBER CORP's EBITDA?

SLEEP NUMBER CORP (SNBRQ) had EBITDA of $9.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is SLEEP NUMBER CORP's gross margin?

SLEEP NUMBER CORP (SNBRQ) had a gross margin of 59.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is SLEEP NUMBER CORP's operating margin?

SLEEP NUMBER CORP (SNBRQ) had an operating margin of -3.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is SLEEP NUMBER CORP's net profit margin?

SLEEP NUMBER CORP (SNBRQ) had a net profit margin of -9.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is SLEEP NUMBER CORP's free cash flow?

SLEEP NUMBER CORP (SNBRQ) recorded an outflow of $17.7M in free cash flow during fiscal year 2025. This represents a -586.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is SLEEP NUMBER CORP's operating cash flow?

SLEEP NUMBER CORP (SNBRQ) recorded an outflow of $3.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are SLEEP NUMBER CORP's total assets?

SLEEP NUMBER CORP (SNBRQ) had $680.1M in total assets as of fiscal year 2025, including both current and long-term assets.

What are SLEEP NUMBER CORP's capital expenditures?

SLEEP NUMBER CORP (SNBRQ) invested $14.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does SLEEP NUMBER CORP spend on research and development?

SLEEP NUMBER CORP (SNBRQ) invested $33.9M in research and development during fiscal year 2025.

Does SLEEP NUMBER CORP buy back shares?

Yes, SLEEP NUMBER CORP (SNBRQ) spent $1.2M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does SLEEP NUMBER CORP have outstanding?

SLEEP NUMBER CORP (SNBRQ) had 23M shares outstanding as of fiscal year 2025.

What is SLEEP NUMBER CORP's current ratio?

SLEEP NUMBER CORP (SNBRQ) had a current ratio of 0.16 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is SLEEP NUMBER CORP's return on assets (ROA)?

SLEEP NUMBER CORP (SNBRQ) had a return on assets of -19.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is SLEEP NUMBER CORP's P/E ratio?

SLEEP NUMBER CORP (SNBRQ) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to April 4, 2026). The market capitalization is $371K as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is SLEEP NUMBER CORP's price-to-sales ratio?

SLEEP NUMBER CORP (SNBRQ) trades at 0.0x sales, its market capitalization divided by revenue of $1.3B revenue, trailing 12 months to April 4, 2026. The market capitalization is $371K as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does SLEEP NUMBER CORP's liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, SLEEP NUMBER CORP (SNBRQ) held $1.7M in cash, cash equivalents and investments, and reported an operating cash outflow of $3.3M over that year. Dividing the one by the other, the reported balance equals about 6 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Why is SLEEP NUMBER CORP's debt-to-equity ratio negative or not reported?

SLEEP NUMBER CORP (SNBRQ) has negative shareholder equity of -$578.5M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is SLEEP NUMBER CORP's Altman Z-Score?

SLEEP NUMBER CORP (SNBRQ) has an Altman Z-Score of -0.75, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is SLEEP NUMBER CORP's Piotroski F-Score?

SLEEP NUMBER CORP (SNBRQ) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are SLEEP NUMBER CORP's earnings high quality?

SLEEP NUMBER CORP (SNBRQ) reported a net loss of $132.0M while operations used $3.3M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can SLEEP NUMBER CORP cover its interest payments?

SLEEP NUMBER CORP (SNBRQ) reported an operating loss of $46.6M against $49.4M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.